RNA Therapy Market by Technology (Enabled Technologies, Enabling Technologies), Application (Cancer, Cardiovascular, Genetic Disorders), End User - Global Forecast 2023-2030

Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. RNA Therapy Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Target Specificity and Selectivity of Treatment and Diagnostics
5.1.1.2. Strategic Alliances & Funding Supported By Pharmaceutical Companies
5.1.1.3. Increased Potential of Virtual Drug Development Models
5.1.2. Restraints
5.1.2.1. Hurdles In Drug Delivery Commercialization
5.1.3. Opportunities
5.1.3.1. Increasing Usage in Cell-Based Cancer Immunotherapy
5.1.3.2. Significance of mRNA Medicine to Treat Deficiency and Genetic Disorders
5.1.3.3. Pipelined Clinical Trials of RNA-Based Therapeutics
5.1.4. Challenges
5.1.4.1. Risk Associated with Investment & Potential Outcomes
5.2. Market Segmentation Analysis
5.2.1. Technology: Enabled technologies elevating the advancements in RNA therapies
5.2.2. End User: Utilization of RNA therapies in drug discovery & development
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization

6. RNA Therapy Market, by Technology
6.1. Introduction
6.2. Enabled Technologies
6.3.1. Inhibition
6.3.2. Labeling
6.3.3. Linear amplification
6.3.4. Microarrays
6.3.5. Purification
6.3.6. qRT-PCR
6.3. Enabling Technologies
6.4.1. RNA Antisense Technologies
6.4.2.1. MicroRNA
6.4.2.2. Small interfering RNA
6.4.2. RNA Interference Technologies

7. RNA Therapy Market, by Application
7.1. Introduction
7.2. Cancer
7.3. Cardiovascular
7.4. Genetic Disorders
7.5. Infectious Diseases
7.6. Kidney Diseases
7.7. Metabolic Disorders
7.8. Oncology
7.9. Retinal Diseases

8. RNA Therapy Market, by End User
8.1. Introduction
8.2. Academic Research
8.3. Diagnostics
8.4. Drug Discovery & Development

9. Americas RNA Therapy Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific RNA Therapy Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa RNA Therapy Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
12.3.1. Agreement, Collaboration, & Partnership
12.3.1.1. Esperovax and Ginkgo Bioworks Announce Partnership to Develop Circular RNA-based Therapeutics
12.3.2. Investment & Funding
12.3.2.1. ADARx Pharmaceuticals, A Leader in Next Generation RNA Therapeutics, Announces Oversubscribed USD 200 Million Series C Financing
12.3.2.2. ReNAgade Therapeutics enters RNA Therapy Arena with USD 300 million

13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Alnylam Pharmaceuticals, Inc.
13.1.2. Arbutus Biopharma Corporation
13.1.3. Arcturus Therapeutics Holdings Inc.
13.1.4. Arrowhead Pharmaceuticals, Inc.
13.1.5. AstraZeneca PLC
13.1.6. Benitec Biopharma Limited
13.1.7. Biogen Inc.
13.1.8. BioNTech SE
13.1.9. Cartesian Therapeutics, Inc.
13.1.10. Cenix BioScience GmbH
13.1.11. Deep Genomics
13.1.12. Eli Lilly and Company
13.1.13. F. Hoffmann-La Roche AG
13.1.14. GSK PLC
13.1.15. Ionis Pharmaceuticals, Inc.
13.1.16. Laronde
13.1.17. MiNA Therapeutics Limited
13.1.18. Moderna, Inc.
13.1.19. NeuBase Therapeutics, Inc.
13.1.20. Nordic Nanovector ASA
13.1.21. Novartis AG
13.1.22. Novo Nordisk A/S
13.1.23. Nutcracker Therapeutics, Inc.
13.1.24. ProQR Therapeutics N.V.
13.1.25. Sanofi S.A.
13.1.26. Silence Therapeutics PLC
13.1.27. Sirnaomics, Inc.
13.1.28. Triplet Therapeutics, Inc.
13.2. Key Product Portfolio

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures

FIGURE 1. RNA THERAPY MARKET RESEARCH PROCESS
FIGURE 2. RNA THERAPY MARKET SIZE, 2022 VS 2030
FIGURE 3. RNA THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. RNA THERAPY MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. RNA THERAPY MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. RNA THERAPY MARKET DYNAMICS
FIGURE 7. RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
FIGURE 8. RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. RNA THERAPY MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 10. RNA THERAPY MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. RNA THERAPY MARKET SIZE, BY END USER, 2022 VS 2030 (%)
FIGURE 12. RNA THERAPY MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS RNA THERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 14. AMERICAS RNA THERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES RNA THERAPY MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 16. UNITED STATES RNA THERAPY MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC RNA THERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC RNA THERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA RNA THERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA RNA THERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. RNA THERAPY MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 22. RNA THERAPY MARKET SHARE, BY KEY PLAYER, 2022

List of Tables

TABLE 1. RNA THERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2022
TABLE 3. RNA THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL RNA THERAPY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 6. RNA THERAPY MARKET SIZE, BY ENABLED TECHNOLOGIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. RNA THERAPY MARKET SIZE, BY ENABLED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 8. RNA THERAPY MARKET SIZE, BY INHIBITION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. RNA THERAPY MARKET SIZE, BY LABELING, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. RNA THERAPY MARKET SIZE, BY LINEAR AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. RNA THERAPY MARKET SIZE, BY MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. RNA THERAPY MARKET SIZE, BY PURIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. RNA THERAPY MARKET SIZE, BY QRT-PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. RNA THERAPY MARKET SIZE, BY ENABLING TECHNOLOGIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. RNA THERAPY MARKET SIZE, BY ENABLING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 16. RNA THERAPY MARKET SIZE, BY RNA ANTISENSE TECHNOLOGIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. RNA THERAPY MARKET SIZE, BY RNA ANTISENSE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 18. RNA THERAPY MARKET SIZE, BY MICRORNA, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. RNA THERAPY MARKET SIZE, BY SMALL INTERFERING RNA, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. RNA THERAPY MARKET SIZE, BY RNA INTERFERENCE TECHNOLOGIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. RNA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 22. RNA THERAPY MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. RNA THERAPY MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. RNA THERAPY MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. RNA THERAPY MARKET SIZE, BY KIDNEY DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. RNA THERAPY MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. RNA THERAPY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. RNA THERAPY MARKET SIZE, BY RETINAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. RNA THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 31. RNA THERAPY MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. RNA THERAPY MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. RNA THERAPY MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS RNA THERAPY MARKET SIZE, BY ENABLED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS RNA THERAPY MARKET SIZE, BY ENABLING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS RNA THERAPY MARKET SIZE, BY RNA ANTISENSE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS RNA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS RNA THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS RNA THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA RNA THERAPY MARKET SIZE, BY ENABLED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA RNA THERAPY MARKET SIZE, BY ENABLING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA RNA THERAPY MARKET SIZE, BY RNA ANTISENSE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA RNA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA RNA THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL RNA THERAPY MARKET SIZE, BY ENABLED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL RNA THERAPY MARKET SIZE, BY ENABLING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL RNA THERAPY MARKET SIZE, BY RNA ANTISENSE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL RNA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL RNA THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 53. CANADA RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 54. CANADA RNA THERAPY MARKET SIZE, BY ENABLED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 55. CANADA RNA THERAPY MARKET SIZE, BY ENABLING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 56. CANADA RNA THERAPY MARKET SIZE, BY RNA ANTISENSE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 57. CANADA RNA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. CANADA RNA THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 59. MEXICO RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 60. MEXICO RNA THERAPY MARKET SIZE, BY ENABLED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 61. MEXICO RNA THERAPY MARKET SIZE, BY ENABLING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 62. MEXICO RNA THERAPY MARKET SIZE, BY RNA ANTISENSE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 63. MEXICO RNA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. MEXICO RNA THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES RNA THERAPY MARKET SIZE, BY ENABLED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES RNA THERAPY MARKET SIZE, BY ENABLING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES RNA THERAPY MARKET SIZE, BY RNA ANTISENSE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES RNA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES RNA THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES RNA THERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 72. ASIA-PACIFIC RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC RNA THERAPY MARKET SIZE, BY ENABLED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 74. ASIA-PACIFIC RNA THERAPY MARKET SIZE, BY ENABLING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC RNA THERAPY MARKET SIZE, BY RNA ANTISENSE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 76. ASIA-PACIFIC RNA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC RNA THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. ASIA-PACIFIC RNA THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 79. AUSTRALIA RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 80. AUSTRALIA RNA THERAPY MARKET SIZE, BY ENABLED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 81. AUSTRALIA RNA THERAPY MARKET SIZE, BY ENABLING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 82. AUSTRALIA RNA THERAPY MARKET SIZE, BY RNA ANTISENSE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 83. AUSTRALIA RNA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. AUSTRALIA RNA THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 85. CHINA RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 86. CHINA RNA THERAPY MARKET SIZE, BY ENABLED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 87. CHINA RNA THERAPY MARKET SIZE, BY ENABLING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 88. CHINA RNA THERAPY MARKET SIZE, BY RNA ANTISENSE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 89. CHINA RNA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. CHINA RNA THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. INDIA RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 92. INDIA RNA THERAPY MARKET SIZE, BY ENABLED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 93. INDIA RNA THERAPY MARKET SIZE, BY ENABLING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 94. INDIA RNA THERAPY MARKET SIZE, BY RNA ANTISENSE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 95. INDIA RNA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. INDIA RNA THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 97. INDONESIA RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 98. INDONESIA RNA THERAPY MARKET SIZE, BY ENABLED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 99. INDONESIA RNA THERAPY MARKET SIZE, BY ENABLING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 100. INDONESIA RNA THERAPY MARKET SIZE, BY RNA ANTISENSE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 101. INDONESIA RNA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. INDONESIA RNA THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 103. JAPAN RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 104. JAPAN RNA THERAPY MARKET SIZE, BY ENABLED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 105. JAPAN RNA THERAPY MARKET SIZE, BY ENABLING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 106. JAPAN RNA THERAPY MARKET SIZE, BY RNA ANTISENSE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 107. JAPAN RNA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. JAPAN RNA THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. MALAYSIA RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 110. MALAYSIA RNA THERAPY MARKET SIZE, BY ENABLED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 111. MALAYSIA RNA THERAPY MARKET SIZE, BY ENABLING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 112. MALAYSIA RNA THERAPY MARKET SIZE, BY RNA ANTISENSE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 113. MALAYSIA RNA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. MALAYSIA RNA THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 115. PHILIPPINES RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 116. PHILIPPINES RNA THERAPY MARKET SIZE, BY ENABLED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 117. PHILIPPINES RNA THERAPY MARKET SIZE, BY ENABLING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 118. PHILIPPINES RNA THERAPY MARKET SIZE, BY RNA ANTISENSE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 119. PHILIPPINES RNA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. PHILIPPINES RNA THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. SINGAPORE RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 122. SINGAPORE RNA THERAPY MARKET SIZE, BY ENABLED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 123. SINGAPORE RNA THERAPY MARKET SIZE, BY ENABLING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 124. SINGAPORE RNA THERAPY MARKET SIZE, BY RNA ANTISENSE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 125. SINGAPORE RNA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. SINGAPORE RNA THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 127. SOUTH KOREA RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 128. SOUTH KOREA RNA THERAPY MARKET SIZE, BY ENABLED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 129. SOUTH KOREA RNA THERAPY MARKET SIZE, BY ENABLING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 130. SOUTH KOREA RNA THERAPY MARKET SIZE, BY RNA ANTISENSE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 131. SOUTH KOREA RNA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. SOUTH KOREA RNA THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 133. TAIWAN RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 134. TAIWAN RNA THERAPY MARKET SIZE, BY ENABLED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 135. TAIWAN RNA THERAPY MARKET SIZE, BY ENABLING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 136. TAIWAN RNA THERAPY MARKET SIZE, BY RNA ANTISENSE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 137. TAIWAN RNA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. TAIWAN RNA THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. THAILAND RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 140. THAILAND RNA THERAPY MARKET SIZE, BY ENABLED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 141. THAILAND RNA THERAPY MARKET SIZE, BY ENABLING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 142. THAILAND RNA THERAPY MARKET SIZE, BY RNA ANTISENSE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 143. THAILAND RNA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. THAILAND RNA THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. VIETNAM RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 146. VIETNAM RNA THERAPY MARKET SIZE, BY ENABLED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 147. VIETNAM RNA THERAPY MARKET SIZE, BY ENABLING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 148. VIETNAM RNA THERAPY MARKET SIZE, BY RNA ANTISENSE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 149. VIETNAM RNA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. VIETNAM RNA THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA RNA THERAPY MARKET SIZE, BY ENABLED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA RNA THERAPY MARKET SIZE, BY ENABLING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA RNA THERAPY MARKET SIZE, BY RNA ANTISENSE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA RNA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA RNA THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA RNA THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 158. DENMARK RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 159. DENMARK RNA THERAPY MARKET SIZE, BY ENABLED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 160. DENMARK RNA THERAPY MARKET SIZE, BY ENABLING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 161. DENMARK RNA THERAPY MARKET SIZE, BY RNA ANTISENSE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 162. DENMARK RNA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. DENMARK RNA THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 164. EGYPT RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 165. EGYPT RNA THERAPY MARKET SIZE, BY ENABLED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 166. EGYPT RNA THERAPY MARKET SIZE, BY ENABLING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 167. EGYPT RNA THERAPY MARKET SIZE, BY RNA ANTISENSE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 168. EGYPT RNA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. EGYPT RNA THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 170. FINLAND RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 171. FINLAND RNA THERAPY MARKET SIZE, BY ENABLED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 172. FINLAND RNA THERAPY MARKET SIZE, BY ENABLING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 173. FINLAND RNA THERAPY MARKET SIZE, BY RNA ANTISENSE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 174. FINLAND RNA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. FINLAND RNA THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 176. FRANCE RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 177. FRANCE RNA THERAPY MARKET SIZE, BY ENABLED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 178. FRANCE RNA THERAPY MARKET SIZE, BY ENABLING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 179. FRANCE RNA THERAPY MARKET SIZE, BY RNA ANTISENSE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 180. FRANCE RNA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. FRANCE RNA THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. GERMANY RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 183. GERMANY RNA THERAPY MARKET SIZE, BY ENABLED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 184. GERMANY RNA THERAPY MARKET SIZE, BY ENABLING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 185. GERMANY RNA THERAPY MARKET SIZE, BY RNA ANTISENSE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 186. GERMANY RNA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. GERMANY RNA THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 188. ISRAEL RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 189. ISRAEL RNA THERAPY MARKET SIZE, BY ENABLED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 190. ISRAEL RNA THERAPY MARKET SIZE, BY ENABLING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 191. ISRAEL RNA THERAPY MARKET SIZE, BY RNA ANTISENSE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 192. ISRAEL RNA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. ISRAEL RNA THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. ITALY RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 195. ITALY RNA THERAPY MARKET SIZE, BY ENABLED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 196. ITALY RNA THERAPY MARKET SIZE, BY ENABLING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 197. ITALY RNA THERAPY MARKET SIZE, BY RNA ANTISENSE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 198. ITALY RNA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. ITALY RNA THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS RNA THERAPY MARKET SIZE, BY ENABLED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 202. NETHERLANDS RNA THERAPY MARKET SIZE, BY ENABLING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 203. NETHERLANDS RNA THERAPY MARKET SIZE, BY RNA ANTISENSE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 204. NETHERLANDS RNA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 205. NETHERLANDS RNA THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 206. NIGERIA RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 207. NIGERIA RNA THERAPY MARKET SIZE, BY ENABLED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 208. NIGERIA RNA THERAPY MARKET SIZE, BY ENABLING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA RNA THERAPY MARKET SIZE, BY RNA ANTISENSE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA RNA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA RNA THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 212. NORWAY RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 213. NORWAY RNA THERAPY MARKET SIZE, BY ENABLED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 214. NORWAY RNA THERAPY MARKET SIZE, BY ENABLING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 215. NORWAY RNA THERAPY MARKET SIZE, BY RNA ANTISENSE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 216. NORWAY RNA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 217. NORWAY RNA THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 218. POLAND RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 219. POLAND RNA THERAPY MARKET SIZE, BY ENABLED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 220. POLAND RNA THERAPY MARKET SIZE, BY ENABLING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 221. POLAND RNA THERAPY MARKET SIZE, BY RNA ANTISENSE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 222. POLAND RNA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. POLAND RNA THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 224. QATAR RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 225. QATAR RNA THERAPY MARKET SIZE, BY ENABLED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 226. QATAR RNA THERAPY MARKET SIZE, BY ENABLING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 227. QATAR RNA THERAPY MARKET SIZE, BY RNA ANTISENSE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 228. QATAR RNA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 229. QATAR RNA THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 230. RUSSIA RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 231. RUSSIA RNA THERAPY MARKET SIZE, BY ENABLED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 232. RUSSIA RNA THERAPY MARKET SIZE, BY ENABLING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 233. RUSSIA RNA THERAPY MARKET SIZE, BY RNA ANTISENSE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 234. RUSSIA RNA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 235. RUSSIA RNA THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 236. SAUDI ARABIA RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA RNA THERAPY MARKET SIZE, BY ENABLED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 238. SAUDI ARABIA RNA THERAPY MARKET SIZE, BY ENABLING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA RNA THERAPY MARKET SIZE, BY RNA ANTISENSE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 240. SAUDI ARABIA RNA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA RNA THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA RNA THERAPY MARKET SIZE, BY ENABLED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 244. SOUTH AFRICA RNA THERAPY MARKET SIZE, BY ENABLING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA RNA THERAPY MARKET SIZE, BY RNA ANTISENSE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 246. SOUTH AFRICA RNA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA RNA THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 248. SPAIN RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 249. SPAIN RNA THERAPY MARKET SIZE, BY ENABLED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 250. SPAIN RNA THERAPY MARKET SIZE, BY ENABLING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 251. SPAIN RNA THERAPY MARKET SIZE, BY RNA ANTISENSE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 252. SPAIN RNA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 253. SPAIN RNA THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 255. SWEDEN RNA THERAPY MARKET SIZE, BY ENABLED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 256. SWEDEN RNA THERAPY MARKET SIZE, BY ENABLING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 257. SWEDEN RNA THERAPY MARKET SIZE, BY RNA ANTISENSE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 258. SWEDEN RNA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 259. SWEDEN RNA THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND RNA THERAPY MARKET SIZE, BY ENABLED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND RNA THERAPY MARKET SIZE, BY ENABLING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND RNA THERAPY MARKET SIZE, BY RNA ANTISENSE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 264. SWITZERLAND RNA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 265. SWITZERLAND RNA THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 266. TURKEY RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 267. TURKEY RNA THERAPY MARKET SIZE, BY ENABLED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 268. TURKEY RNA THERAPY MARKET SIZE, BY ENABLING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 269. TURKEY RNA THERAPY MARKET SIZE, BY RNA ANTISENSE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 270. TURKEY RNA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 271. TURKEY RNA THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES RNA THERAPY MARKET SIZE, BY ENABLED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES RNA THERAPY MARKET SIZE, BY ENABLING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES RNA THERAPY MARKET SIZE, BY RNA ANTISENSE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES RNA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES RNA THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 278. UNITED KINGDOM RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM RNA THERAPY MARKET SIZE, BY ENABLED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 280. UNITED KINGDOM RNA THERAPY MARKET SIZE, BY ENABLING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM RNA THERAPY MARKET SIZE, BY RNA ANTISENSE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 282. UNITED KINGDOM RNA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM RNA THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 284. RNA THERAPY MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 285. RNA THERAPY MARKET SHARE, BY KEY PLAYER, 2022
TABLE 286. RNA THERAPY MARKET LICENSE & PRICING